Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;169(3):e70026.
doi: 10.1111/jnc.70026.

CPNE7 Regulates Amyloidogenesis Through CAP1-Dependent ADAM10 Translation

Affiliations

CPNE7 Regulates Amyloidogenesis Through CAP1-Dependent ADAM10 Translation

Jie Yang et al. J Neurochem. 2025 Mar.

Abstract

The accumulation of amyloid plaques is a pathological hallmark of Alzheimer's disease (AD), in which ADAM10, the α-secretase that catalyzes APP and facilitates the non-amyloidogenesis pathway, plays an important role. We have previously reported that the expression of copine-7 (Cpne7) in the hippocampus of APP/PS1 mice is significantly upregulated by nicotine, whereas the potential role of CPNE7 in AD remains largely unknown. Here, we report that CPNE7 protein levels are significantly decreased in APP/PS1 mice and HEK293 cells stably expressing full-length APP. CPNE7 is shown to reduce Aβ levels by favoring ADAM10 activity, and the elevated ADAM10 protein by CPNE7 involves a translational mechanism. Further transcriptome profiling reveals that CPNE7 differentially regulates genes associated with neuronal function. Among these, cyclase-associated actin cytoskeleton regulatory protein 1 (CAP1) is identified as a target gene of CPNE7, which controls ADAM10 translation through binding to the 5' untranslated region (5'UTR). Collectively, the CPNE7-CAP1 axis could be critical in the amyloidogenic pathway by regulating ADAM10 translation, in which the RNA binding activity of CAP1 is highlighted.

Keywords: ADAM10; Alzheimer's disease (AD); CAP1; CPNE7; RNA‐binding protein (RBP).

PubMed Disclaimer

References

    1. Agarwal, M., and S. Khan. 2020. “Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review.” Cureus 12, no. 12: e12008. https://doi.org/10.7759/cureus.12008.
    1. Bai, S., J. H. Lee, C. Son, D. S. Lee, and J. C. Park. 2022. “CPNE7 Regenerates Periodontal Ligament via TAU‐Mediated Alignment and Cementum Attachment Protein‐Mediated Attachment.” Journal of Clinical Periodontology 49, no. 6: 609–620. https://doi.org/10.1111/jcpe.13621.
    1. Baranello, R. J., K. L. Bharani, V. Padmaraju, et al. 2015. “Amyloid‐Beta Protein Clearance and Degradation (ABCD) Pathways and Their Role in Alzheimer's Disease.” Current Alzheimer Research 12, no. 1: 32–46. https://doi.org/10.2174/1567205012666141218140953.
    1. Beata, B. K., J. Wojciech, K. Johannes, L. Piotr, and M. Barbara. 2023. “Alzheimer's Disease—Biochemical and Psychological Background for Diagnosis and Treatment.” International Journal of Molecular Sciences 24, no. 2: 1059. https://doi.org/10.3390/ijms24021059.
    1. Bottomley, M. J., K. Salim, and G. Panayotou. 1998. “Phospholipid‐Binding Protein Domains.” Biochimica et Biophysica Acta 1436, no. 1–2: 165–183. https://doi.org/10.1016/s0005‐2760(98)00141‐6.

MeSH terms

LinkOut - more resources